Your browser doesn't support javascript.
loading
Farnesoid X receptor antagonizes JNK signaling pathway in liver carcinogenesis by activating SOD3.
Wang, Yan-Dong; Chen, Wei-Dong; Li, Cunbao; Guo, Cong; Li, Yanyan; Qi, Hui; Shen, Hailing; Kong, Jing; Long, Xuecheng; Yuan, Frank; Wang, Xichun; Huang, Wendong.
Affiliation
  • Wang YD; State Key Laboratory of Chemical Resource Engineering (Y.-D.W., C.G., X.L.), College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, People's Republic of China; Pathogenic Organisms and Immunology Lab (W.-D.C., C.L.), School of basic medical science, Inner Mongolia Medical University, Hohhot, 010110, Inner Mongolia, People's Republic of China; Key Laboratory of Receptors-Mediated Gene Regulation and Drug Discovery (W.D.C., Y.L., H.Q., H.S., J.K.), Scho
Mol Endocrinol ; 29(2): 322-31, 2015 Feb.
Article in En | MEDLINE | ID: mdl-25496033

Full text: 1 Database: MEDLINE Main subject: Superoxide Dismutase / Receptors, Cytoplasmic and Nuclear / MAP Kinase Signaling System / JNK Mitogen-Activated Protein Kinases / Carcinogenesis / Liver Neoplasms Limits: Animals / Humans / Male Language: En Journal: Mol Endocrinol Journal subject: BIOLOGIA MOLECULAR / ENDOCRINOLOGIA Year: 2015 Type: Article

Full text: 1 Database: MEDLINE Main subject: Superoxide Dismutase / Receptors, Cytoplasmic and Nuclear / MAP Kinase Signaling System / JNK Mitogen-Activated Protein Kinases / Carcinogenesis / Liver Neoplasms Limits: Animals / Humans / Male Language: En Journal: Mol Endocrinol Journal subject: BIOLOGIA MOLECULAR / ENDOCRINOLOGIA Year: 2015 Type: Article